证券代码：688337 证券简称：普源精电 公告编号：2025-033 普源精电科技股份有限公司 关于 2024 年年度权益分派实施后 调整回购价格上限的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示 一、 回购股份的基本情况 2025 年 4 月 29 日，公司召开第二届董事会第二十六次会议，审议通过了《关 于以集中竞价交易方式回购公司股份方案的议案》，公司董事会同意公司使用自 有资金通过上海证券交易所系统以集中竞价交易方式回购公司已发行的部分人 民币普通股（A 股），在未来适宜时机用于股权激励计划。回购股份的资金总额 不低于人民币 3,000.00 万元（含）,不超过人民币 5,000.00 万元（含）。回购股 份的价格不超过人民币 56.79 元/股（含），回购期限为自董事会审议通过回购股 份方案之日起不超过 12 个月。具体内容详见 2025 年 4 月 30 日公司在上海证券 交易所网站（www.sse.com.cn）披露的《普源精电科技股份有限公司关于以集中 竞价交易方式回购股份的回购报告书 ...

Core Viewpoint - The company has announced a cash dividend of 0.40 yuan per share for the 2024 fiscal year, which was approved at the annual shareholders' meeting on June 25, 2025 [1][2]. Distribution Plan - The dividend distribution plan for the 2024 fiscal year includes a cash dividend of 4 yuan for every 10 shares held, with a total of 193,752,463 shares eligible for distribution after accounting for shares in the repurchase account [2][3]. - The total cash dividend to be distributed amounts to approximately 77.5 million yuan (including tax) [2]. Dividend Calculation Basis - The reference price for the ex-dividend calculation is determined by subtracting the cash dividend from the previous closing price, with no change in the number of circulating shares [3]. - The virtual cash dividend per share is calculated as approximately 0.40 yuan [3]. Relevant Dates - The dividend will be distributed to all shareholders registered with the China Securities Depository and Clearing Corporation Limited, Shanghai Branch, after the market closes on the record date [5]. Implementation Method - The company will distribute dividends through the China Securities Depository and Clearing Corporation Limited, and shareholders who have designated transactions can collect their cash dividends on the payment date [5][6]. Tax Deduction Explanation - Individual shareholders holding shares for over one year are exempt from personal income tax on dividend income, while those holding for one year or less will have taxes calculated upon the sale of shares [7][8]. - For qualified foreign institutional investors (QFII), a 10% corporate income tax will be withheld, resulting in a net cash dividend of 0.36 yuan per share [9].

Core Viewpoint - The company has announced a differentiated cash dividend distribution plan for the fiscal year 2024, which was approved at the annual shareholders' meeting on June 25, 2025, with a cash dividend of 0.40 RMB per share [1][2]. Dividend Distribution Plan - The company plans to distribute a cash dividend of 4 RMB for every 10 shares held, totaling approximately 193,752,463 shares eligible for the distribution, resulting in a total cash dividend payout of around 77.5 million RMB [1][2]. - The cash dividend will be distributed without issuing new shares or increasing the capital reserve, maintaining the total distribution amount despite any changes in the total share capital due to share buybacks or other corporate actions [1][2]. Relevant Dates - Key dates for the dividend distribution include the record date, ex-dividend date, and cash dividend payment date, which are specified in the announcement [2]. Tax Implications - For individual shareholders holding shares for over one year, the cash dividend of 0.40 RMB per share is exempt from personal income tax. For those holding shares for one year or less, the tax will be calculated upon the sale of the shares [3][4]. - For qualified foreign institutional investors (QFII), a 10% withholding tax will be applied, resulting in a net cash dividend of 0.36 RMB per share [5]. - Other corporate shareholders will be responsible for their own tax declarations, with a gross cash dividend of 0.40 RMB per share [5]. Contact Information - For inquiries regarding the dividend distribution, shareholders can contact the company's board of directors at the provided phone number [6].

国泰海通证券股份有限公司关于 普源精电科技股份有限公司差异化分红事项的核查意见 国泰海通证券股份有限公司（以下简称"保荐机构"）作为普源精电科技股 份有限公司（以下简称"公司"、"普源精电"或"发行人"）首次公开发行股 票并在科创板上市、2023年以简易程序向特定对象发行股票的保荐机构及持续督 导机构，根据《中华人民共和国公司法》《中华人民共和国证券法》《证券发行 上市保荐业务管理办法》《上市公司股份回购规则》《上海证券交易所上市公司 自律监管指引第7号——回购股份》《上海证券交易所上市公司自律监管指南第 2号——业务办理》等法律法规，对公司2024年度利润分配所涉及的差异化分红 相关事项进行了审慎核查，核查情况及核查意见如下： 一、差异化分红原因 2024年2月4日，公司召开第二届董事会第十四次会议，审议通过了《关于以 集中竞价交易方式回购公司股份方案的议案》，公司董事会同意公司使用自有资 金通过上海证券交易所系统以集中竞价交易方式回购公司已发行的部分人民币 普通股（A股），在未来适宜时机用于股权激励计划。回购股份的资金总额不低 于人民币3,000.00万元（含），不超过人民币5,000.00万元（含）。回 ...

证券代码：688337 证券简称：普源精电 公告编号：2025-032 普源精电科技股份有限公司 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： | 股权登记日 | 除权（息）日 | 现金红利发放日 | | --- | --- | --- | | 2025/7/17 | 2025/7/18 | 2025/7/18 | 一、 通过分配方案的股东大会届次和日期 本次利润分配方案经公司2025年 6月 25 日的2024年年度股东大会审议通过。 二、 分配方案 1. 发放年度：2024年年度 2. 分派对象： 2024年年度权益分派实施公告 截至股权登记日下午上海证券交易所收市后，在中国证券登记结算有限责任 公司上海分公司（以下简称"中国结算上海分公司"）登记在册的本公司全体股东。 3. 差异化分红送转方案： （1） 本次差异化分红方案 是否涉及差异化分红送转：是 每股分配比例 每股现金红利0.40元 相关日期 根据公司 2024 年年度股东大会审议通过的《关于公司 2024 年度利润分配方 案的议案》，公司 20 ...

Industry Rating - The report maintains an "Outperform" rating for the scientific instruments industry, consistent with the previous rating [1]. Core Insights - The scientific instruments market in China surpassed 220 billion yuan in 2023, with a growth rate exceeding 12%. The market is dominated by high-end foreign brands, and there is a significant push for domestic alternatives driven by government policies [2][12]. - The domestic market for mass spectrometers reached 16.712 billion yuan in 2023, with foreign companies holding over 90% of the global market share. The import rate for mass spectrometers has decreased from 89% in 2018 to 81% in 2023, indicating a gradual shift towards domestic production [3][41]. - The electronic measurement instruments market is projected to exceed 40 billion yuan in 2024, with a notable focus on mid-to-high-end products. The market for oscilloscopes is expected to reach 650 million USD by 2025 [4]. Summary by Sections 1. Scientific Instruments Industry - The scientific instruments industry is characterized by high-end foreign brands dominating the market, while domestic brands struggle to gain market share. The government has introduced various policies to promote domestic innovation and application of scientific instruments [2][24]. 2. Scientific Analysis Instruments - The market for scientific analysis instruments is vast, with mass spectrometers and chromatographs showing low domestic production rates. The mass spectrometer market is expected to grow significantly, with a focus on high-resolution and triple quadrupole models as key areas for domestic manufacturers to target [25][50]. 3. Electronic Measurement Instruments - The electronic measurement instruments market is rapidly expanding, with a projected market size of 16.307 billion USD globally by 2024. The domestic market is expected to exceed 40 billion yuan, with a significant portion of high-end products still being imported [4][6]. 4. Policy Guidance - Recent government policies have aimed to support the development of domestic scientific instruments, including tax exemptions for imported instruments used in research and education, which will lower costs for research institutions [21][24].

证券代码：688337 证券简称：普源精电 公告编号：2025-031 普源精电科技股份有限公司 7 号——回购股份》的相关规定，公司在回购期间，应当在每个月的前 3 个交易 日内公告截至上月末的回购进展情况。现将回购股份的进展情况公告如下： 截至 2025 年 6 月 30 日，公司尚未实施股份回购。 重要内容提示： | 回购方案首次披露日 | 2025/4/30 | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 回购方案实施期限 | 年 日~2026 2025 4 | 4 | 月 | 29 | 年 | 月 | 28 | 日 | | 预计回购金额 | 3,000万元~5,000万元 | | | | | | | | | 回购用途 | □减少注册资本 √用于员工持股计划或股权激励 | | | | | | | | | | □用于转换公司可转债 □为维护公司价值及股东权益 | | | | | | | | | 累计已回购股数 | 0万股 | | | | | | | | | 累计已回购股数占总股本比例 | 0% | | | ...

Core Viewpoint - Megatech Co., Ltd. has submitted its listing application to the Hong Kong Stock Exchange, aiming to capitalize on its position as a leading provider of autonomous intelligent systems in the robotics technology application sector in China [3]. Company Overview - Established in 2016, Megatech is recognized as a national-level "specialized and innovative" small giant enterprise and has been listed among the "50 Smartest Companies" by MIT Technology Review [3]. - The company is primarily focused on the sales of autonomous intelligent systems and multi-agent solutions [12]. Financial Performance - Megatech's revenue for the years 2022, 2023, and 2024 is projected to be approximately RMB 455 million, RMB 663 million, and RMB 930 million, respectively [12]. - The company has reported losses of approximately RMB 759 million, RMB 742 million, and RMB 780 million for the same years [12]. Shareholding Structure - The largest shareholder group, consisting of Huang Yuqing, Qiao Zhixin, Zhang Yan, and others, collectively holds about 16.08% of the company's issued share capital [3]. Leadership Team - Huang Yuqing, the founder, chairman, executive director, and CEO, oversees the overall business strategy and management of the company [6]. - Qiao Zhixin serves as the co-founder, executive director, and COO, responsible for internal operations [10]. - Zhang Yan is also a co-founder and executive director, focusing on the management of the smart laboratory business [11].

Core Insights - The article analyzes the salary situation of R&D and sales employees in 50 listed instrument companies in China, highlighting the competitive landscape for talent in the industry [2][3]. R&D Salary Analysis - The average annual salary for R&D personnel in listed instrument companies for 2024 is 232,900 yuan, reflecting a slight increase of 2.64% compared to 2023, indicating a growing emphasis on R&D talent [3]. - There is a significant disparity in R&D salaries among companies, with Mindray Medical leading at 505,100 yuan per year, followed by Puyuan Precision, Meiya Optoelectronics, and others, while some companies offer as low as 100,000 yuan per year [3][5]. - The salary gap may lead to a concentration of R&D talent in top companies, exacerbating the competitive imbalance in the industry [4]. Sales Salary Analysis - The average annual salary for sales personnel in 2024 is 334,000 yuan, showing a growth of 3.66% from the previous year, indicating an increasing reliance on sales teams in a competitive market [9]. - Mindray Medical, Meiya Optoelectronics, and others top the sales salary rankings, with Mindray's sales personnel earning 729,600 yuan per year, reflecting the high value placed on sales talent [9][11]. - The high salary levels in the sales sector are attributed to the technical complexity and high price of instrument products, necessitating skilled sales personnel [10]. Salary Rankings and Implications - The article provides detailed rankings of R&D and sales salaries, showcasing the top 30 companies in each category, which serves as a reflection of the industry's current state [5][11]. - High salaries are often associated with strong performance in technology innovation and market expansion, while lower salaries may lead to talent loss and reduced innovation capacity [14]. - For job seekers, the salary rankings serve as a reference point, emphasizing the importance of considering a company's growth potential and culture alongside salary [14]. Future Outlook - The importance of R&D and sales talent is expected to grow as the instrument industry continues to develop, highlighting the need for companies to attract and nurture talent through competitive compensation and supportive work environments [15].

Investment Rating - The investment rating for the company is "Outperform" (maintained) [1] Core Views - The company has signed a cooperation agreement with Xi'an University of Electronic Science and Technology to promote its high-end strategy, focusing on deep integration of industry, academia, and research [6] - The company is committed to high-end product development and has seen significant sales growth in its DS80000 series high-end digital oscilloscopes, with strong demand from strategic customers [6] - The electronic measurement instrument industry is expected to continue steady growth, with domestic companies accelerating their technological advancements and narrowing the gap with overseas competitors [6] Financial Data and Profit Forecast - Total revenue is projected to grow from 776 million in 2024 to 1,332 million by 2027, with a compound annual growth rate (CAGR) of approximately 18.2% [5][8] - The net profit attributable to the parent company is expected to increase from 92 million in 2024 to 262 million by 2027, reflecting a significant growth trajectory [5][8] - The company's gross margin is forecasted to improve from 59.1% in 2024 to 62.7% in 2027, indicating enhanced profitability [5]